Reference

Method using nutritional supplements for treating amyotrophic lateral sclerosis

Method using nutritional supplements for treating amyotrophic lateral sclerosis. Kane, Patricia; Kane, Edward (Bodybio Corporation, USA). U.S. Pat. Appl. Publ. US 2005019423 A1 27 Jan 2005, 11 pp. (English). (United States of America). CODEN: USXXCO. CLASS: ICM: A61K031-685. ICS: A61K031-202. APPLICATION: US 2004-946601 21 Sep 2004. 5743-36-2 and 14127-61-8 are also in the experiment. DOCUMENT TYPE: Patent CA Section: 1 (Pharmacology) Section cross-reference(s): 18 The administration of nutritional supplements such as phosphatidylcholine; linoleic acid and a-linoleic acid in an approx. 4:1 (vol./vol.) ratio; and mineral supplements provides an effective method for the treatment of amyotrophic lateral sclerosis (ALS). Subjects presenting with symptoms indicative of ALS can therefore be treated with these nutritional supplements to inhibit progression of ALS. Subjects at risk for developing ALS can also be treated with these nutritional supplements to delay the onset of ALS symptoms. .